These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28389199)

  • 1. Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in Sweden.
    Sabale U; Bodegard J; Svennblad B; Östgren CJ; Johansson G; Ekman M; Henriksson M; Nilsson P
    Prim Care Diabetes; 2017 Jun; 11(3):217-225. PubMed ID: 28389199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting.
    Sabale U; Bodegård J; Sundström J; Östgren CJ; Nilsson P; Johansson G; Svennblad B; Henriksson M
    Prim Care Diabetes; 2015 Oct; 9(5):330-7. PubMed ID: 25631469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.
    Dilla T; Valladares A; Nicolay C; Salvador J; Reviriego J; Costi M
    Appl Health Econ Health Policy; 2012 Nov; 10(6):417-30. PubMed ID: 23013427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice.
    Kalkan A; Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PN; Johansson G; Ekman M
    Prim Care Diabetes; 2017 Apr; 11(2):184-192. PubMed ID: 27894781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Burden of Obesity by Glycemic Stage in the United States.
    Li Q; Blume SW; Huang JC; Hammer M; Graf TR
    Pharmacoeconomics; 2015 Jul; 33(7):735-48. PubMed ID: 25564434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: two-year experience from the INSTIGATE study.
    Aloumanis K; Benroubi M; Sourmeli S; Drossinos V
    Prim Care Diabetes; 2013 Oct; 7(3):235-42. PubMed ID: 23623608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study.
    Janzon M; Henriksson M; Hasvold P; Hjelm H; Thuresson M; Jernberg T
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):291-298. PubMed ID: 29474723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class.
    Blak BT; Rigney U; Sternhufvud C; Davis J; Hammar N
    Int J Clin Pract; 2016 Jan; 70(1):45-55. PubMed ID: 26620492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30-35. The role of sRAGE biomarker as predictor of satisfactory outcomes.
    Horwitz D; Saunders JK; Ude-Welcome A; Marie Schmidt A; Dunn V; Leon Pachter H; Parikh M
    Surg Obes Relat Dis; 2016 Aug; 12(7):1337-1341. PubMed ID: 27134202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.
    Yu AP; Wu EQ; Birnbaum HG; Emani S; Fay M; Pohl G; Wintle M; Yang E; Oglesby A
    Curr Med Res Opin; 2007 Sep; 23(9):2157-69. PubMed ID: 17669232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.
    Gillett M; Dallosso HM; Dixon S; Brennan A; Carey ME; Campbell MJ; Heller S; Khunti K; Skinner TC; Davies MJ
    BMJ; 2010 Aug; 341():c4093. PubMed ID: 20729270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Care Costs Associated With Long-term Weight Maintenance Versus Weight Gain Among Patients With Type 2 Diabetes.
    Nichols GA; Bell K; Kimes TM; O'Keeffe-Rosetti M
    Diabetes Care; 2016 Nov; 39(11):1981-1986. PubMed ID: 27561921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.
    Hasvold P; Nordanstig J; Kragsterman B; Kristensen T; Falkenberg M; Johansson S; Thuresson M; Sigvant B
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):10-17. PubMed ID: 28950310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic study.
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Ibánez-Nolla J
    Eur Addict Res; 2014; 20(2):94-104. PubMed ID: 24192535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare utilization, screening, and costs among participants in the Southeastern Diabetes Initiative: A population-based evaluation.
    Van Houtven CH; Greiner MA; Heidenfelder B; Spratt SE; Granger BB; Dunham AA; Qualls LG; Curtis LH
    Prim Care Diabetes; 2018 Apr; 12(2):172-183. PubMed ID: 29102500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of weight change in patients with type 2 diabetes mellitus.
    Bell K; Parasuraman S; Shah M; Raju A; Graham J; Lamerato L; D'Souza A
    Am J Manag Care; 2014 Aug; 20(8):e320-9. PubMed ID: 25295795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study.
    Kent S; Jebb SA; Gray A; Green J; Reeves G; Beral V; Mihaylova B; Cairns BJ;
    Int J Obes (Lond); 2019 Sep; 43(9):1839-1848. PubMed ID: 30568274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States.
    Aagren M; Luo W
    J Med Econ; 2011; 14(1):108-14. PubMed ID: 21241161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.
    Jans A; Näslund I; Ottosson J; Szabo E; Näslund E; Stenberg E
    PLoS Med; 2019 Nov; 16(11):e1002985. PubMed ID: 31747392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.